Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2019, Nation 1 VC operates from San Francisco and Prague, managing $60 million across two funds. The firm focuses on early-stage investments in artificial intelligence and health technology, supporting founders from inception to global impact.
Nation 1 VC invests in early-stage companies within the AI, healthtech, and frontier technology sectors. Typical investments range from $100,000 to $1 million, targeting startups in North America and Europe with a global scaling intent.
Notable portfolio companies include Myriad AI, which develops AI-powered assistants for clinic administration; TrueClaim, providing AI healthcare support; Scalpel AI, focused on governance infrastructure for clinical AI; and Taikun, which exited to Cloudera after transitioning from Prague to Silicon Valley.
Submit your pitch through their form at nation1.vc.
Yes, Nation 1 VC often leads investment rounds, particularly in their focus sectors of AI and health technology.
The firm is open to follow-on investments, especially for portfolio companies demonstrating significant growth potential.
Nation 1 VC manages $60 million across two funds, focusing on early-stage investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.